The Role of Palliative Care in Reducing Symptoms and Improving Quality of Life for Patients with Idiopathic Pulmonary Fibrosis: A Review
Abstract Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with a median survival of 3–4 years from time of initial diagnosis, similar to the time course of many malignancies. A hallmark of IPF is its unpredictable disease course, ranging from long periods of clinical stabil...
Main Authors: | Richard H. Zou, Daniel J. Kass, Kevin F. Gibson, Kathleen O. Lindell |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-01-01
|
Series: | Pulmonary Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s41030-019-00108-2 |
Similar Items
-
Pulmonologists' Perspectives on and Access to Palliative Care for Patients With Idiopathic Pulmonary Fibrosis in South Carolina
by: Kathleen Oare Lindell, et al.
Published: (2023-10-01) -
The impact of palliative care on quality of life, anxiety, and depression in idiopathic pulmonary fibrosis: a randomized controlled pilot study
by: Katherine Janssen, et al.
Published: (2020-01-01) -
Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01) -
Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data
by: Joo Heung Yoon, et al.
Published: (2018-10-01) -
End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation
by: Norimichi Akiyama, et al.
Published: (2022-10-01)